Supplier's Corner

Enzymotec Announces New DHA-Based Supplement

October 31, 2005

Enzymotec has developed a new DHA-delivery system that is capable of improving DHA bio-availability.
Earlier this year Enzymotec had concluded an animal and human study on a proprietary structured derivative of the DHA-phospholipid system, exhibiting a better DHA availability over fish DHA or mixtures of DHA and phospholipids and consequently a superior biological effect, thus supporting past scientific literature and the benefits of using advanced DHA delivery systems.
Enzymotec, a lipid nutrition company, is the developer and producer of CardiaBeat for CVD prevention, SharpPS for cognitive enhancement, and InFat for better calcium and energy absorptions as well as easy digestion for infants. More info: Orly Farkash, orly@enzymotec.com; 972-4-6545112.

blog comments powered by Disqus
  • Innovation On Display

    Melissa Meisel, Associate Editor||February 3, 2016
    P&G Beauty Digital Studio showcases new products for 2016

  • Crowning Glory

    Crowning Glory

    Christine Esposito , Associate Editor||February 3, 2016
    Celebrity stylists and experts from leading hair care brands talk about the ingredients and formats driving the styling sector.

  • Electric Slide

    Electric Slide

    Melissa Meisel, Associate Editor||February 3, 2016
    Skin care devices bring anti-aging to the next level